Description

Salbroxol (ambroxol, salbutamol) tablets №20

Ingredients

Each tablet contains: Ambroxol 30mg and Salbutamol 2mg.

Dosage

Adults: Take 1 tablet three times a day. Children: Consult a healthcare professional for appropriate dosage.

Indications

Salbroxol tablets are indicated for the treatment of respiratory conditions such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD).

Contraindications

Do not use Salbroxol tablets if you are allergic to ambroxol, salbutamol, or any other ingredients in the formulation. Consult your doctor before use if you have a history of heart conditions or high blood pressure.

Directions

Swallow the tablets whole with a glass of water. Do not crush or chew the tablets. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Ambroxol is known for its mucolytic properties, helping to break down mucus in the airways, making it easier to cough up. Salbutamol, on the other hand, is a bronchodilator that helps to relax the muscles in the airways, making breathing easier. The combination of these two ingredients in Salbroxol tablets provides dual action in treating respiratory conditions.

Additional Information

It is important to complete the full course of treatment with Salbroxol tablets as prescribed by your healthcare provider, even if you start to feel better. If you experience any severe side effects or allergic reactions, seek medical attention immediately.

Pharmacological studies have shown that ambroxol enhances the production of surfactant in the lungs, which helps improve lung function and reduce the risk of respiratory infections. Salbutamol, on the other hand, acts by stimulating beta-2 adrenergic receptors in the airways, leading to bronchodilation and improved airflow.

Clinical trials have demonstrated the efficacy of ambroxol and salbutamol in improving symptoms of respiratory conditions such as bronchitis and asthma. A study published in the International Journal of Chronic Obstructive Pulmonary Disease showed that the combination of ambroxol and salbutamol resulted in significant improvements in lung function and symptom control in patients with COPD.